Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PHSTX vs. XLV: which is better?

Bottom line

PHSTX vs XLV: the short answer

PHSTX (Putnam Global Health Care Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.

XLV is cheaper at 0.08% vs 1.04% — a difference of $96 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +6.5% for PHSTX (reporting dates differ).

PHSTX has a front-end sales load of up to 5.75%; the other does not.

Updated Nov 19, 2026

PHSTX vs XLV side by side

PHSTXXLV
TypeMutual fundETF
Fund familyFranklin TempletonSPDR (State Street)
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.04%0.08%
Annual cost per $10k$104$8
10-yr cost on $10k (prospectus)$1,772$103
Max front load5.75%None
12b-1 fee0.25%0.02%
1-yr return−4.6%+14.5%
5-yr return (annualized)+6.5%+8.1%
10-yr return (annualized)+6.9%+9.8%
Best quarter+17.5%+14.5%
Worst quarter−12.3%−12.7%
Net assets (fund)$1.5B$40.6B
Number of holdings11565
Portfolio turnover67%2%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPHSTXXLVDifference
2024+1.3%+2.5%−1.2%
2023+9.0%+2.0%+7.0%
2022−4.7%−2.1%−2.7%
2021+19.4%+25.9%−6.5%
2020+15.9%+13.3%+2.7%
2019+30.2%+20.7%+9.6%
2018−0.6%+6.3%−6.9%
2017+15.3%+21.7%−6.4%
2016−11.7%−2.8%−8.9%

Source: Fund prospectus bar charts

Holdings overlap

16 of PHSTX's top 25 holdings also appear in XLV's top 25.

Shared top holdings
HoldingPHSTXXLV
Eli Lilly & Co.13.15%16.51%
Johnson & Johnson8.46%10.64%
UnitedHealth Group, Inc.6.93%6.57%
AbbVie, Inc.6.05%7.74%
Merck & Co., Inc.4.88%5.52%
Thermo Fisher Scientific, Inc.4.50%3.24%
Intuitive Surgical, Inc.4.04%2.45%
CVS Health Corp.2.74%2.30%
Gilead Sciences, Inc.2.63%2.73%
McKesson Corp.2.14%1.58%
Cardinal Health, Inc.2.12%0.97%
Vertex Pharmaceuticals, Inc.1.97%2.19%
Boston Scientific Corp.1.80%1.10%
Bristol-Myers Squibb Co.1.75%2.05%
HCA Healthcare, Inc.1.18%1.05%

Source: SEC Form N-PORT

PHSTX top 10

  1. Eli Lilly & Co. — 13.15%
  2. Johnson & Johnson — 8.46%
  3. UnitedHealth Group, Inc. — 6.93%
  4. AbbVie, Inc. — 6.05%
  5. Novartis AG — 5.13%
  6. Merck & Co., Inc. — 4.88%
  7. AstraZeneca plc — 4.67%
  8. Thermo Fisher Scientific, Inc. — 4.50%
  9. Intuitive Surgical, Inc. — 4.04%
  10. Sanofi SA — 3.23%

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

FAQ

What is the difference between PHSTX and XLV?
PHSTX (Putnam Global Health Care Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. XLV is cheaper at 0.08% vs 1.04% — a difference of $96 a year per $10,000 invested.
Which is cheaper, PHSTX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both PHSTX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.